TotalMarketCap

Bicara Therapeutics

BCAXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$542.618 M

$8.20 -7.76%

Close of 6 Nov 2026

As of 6 Nov 2026, Bicara Therapeutics (BCAX) has a market capitalization of $542.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$137.9M

Loss-making

Shares outstanding

66,172,934

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #180ApnimedAPMD$589.1M
  2. #181Arbutus BiopharmaABUS$561.8M
  3. #182Bicara TherapeuticsBCAX$542.6M
  4. #183Aclaris TherapeuticsACRS$529.9M
  5. #184NeurogeneNGNE$516.1M

What if Bicara Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$426,713.34

Per share 52,038× higher

Bitcoin $1.53T

$23,088.72

Per share 2,816× higher

Apple $5.02T

$75,798.10

Per share 9,244× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Bicara Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.